New Phase I/II Trial for Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Multiple Myeloma is Now Underway!

The very first patient in Medigene AG's clinical trial examining MDG1011 has officially received the treatment. This is the company's first human clinical trial for this TCR therapy. The trial…

Continue Reading New Phase I/II Trial for Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Multiple Myeloma is Now Underway!
Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients
skeeze / Pixabay

Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients

According to a story from EurekAlert!, a recent study revealed that the surgical removal of the thymus gland, known as a thymectomy, was able to provide long-term benefits for patients…

Continue Reading Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients
For This Woman With Arthrogryposis Multiplex Congenita, This New Barbie is Life-Changing
Alexas_Fotos / Pixabay

For This Woman With Arthrogryposis Multiplex Congenita, This New Barbie is Life-Changing

According to a story from the Huffington Post, a recent Instagram post from the Barbie brand of dolls indicates that the company is beginning to expand its line of dolls…

Continue Reading For This Woman With Arthrogryposis Multiplex Congenita, This New Barbie is Life-Changing
First Patient Receives Treatment in Pulmonary Arterial Hypertension Clinical Trial
kalhh / Pixabay

First Patient Receives Treatment in Pulmonary Arterial Hypertension Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company Complexa, Inc. recently announced that it has dosed the first patient in its Phase 2 clinical trial which is testing the…

Continue Reading First Patient Receives Treatment in Pulmonary Arterial Hypertension Clinical Trial

Interim Data for Phase 3 Graft-versus-Host Disease Trial Looks Promising

According to a story from PR Newswire, the specialty pharmaceutical company Mallinckrodt plc recently announced the release of interim data from the company's Phase 3 clinical trial. This trial is…

Continue Reading Interim Data for Phase 3 Graft-versus-Host Disease Trial Looks Promising

Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients

What is the Patient Advocate Foundation? The Patient Advocate Foundation (PAF) is a non-profit, formed in 1994 that has one primary aim- eliminate the barriers to treatment too many patients…

Continue Reading Patient Advocate Foundation Provides Co-Pay Relief for Rare Disease Patients
67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy
source: pixabay.com

67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy

  A grandmother of four in Maryland has recently become the first cancer patient to complete the experimental CAR-T cell procedure at Georgetown University Hospital. Daisy Diggs 67, who was…

Continue Reading 67 Year Old Non-Hodgkin’s Lymphoma Patient Given Second Chance at Life After Experimental Cell Therapy